Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-12 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.21 | 6e-10 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-09 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-09 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-08 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-08 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-07 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-07 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-07 |